Disclosures: Xiangzhu Zhu: Nothing to Disclose, Xinyuan Zhang: Nothing to Disclose, Shakirat Salvador: Nothing to Disclose, Xuehong Zhang: Nothing to Disclose, Martha Shrubsole: Nothing to Disclose, Manhal Izzy: Mallinckrodt: Speaking and Teaching, Qi Dai: Nothing to Disclose 1199 EXAMINING THE PREVALENCE OF HEPATIC STEATOSIS AND ADVANCED FIBROSIS USING MULTIPLE NON-INVASIVE MEASURES IN CANADA: A NATIONAL ESTIMATE USING THE CANADIAN HEALTH MEASURES SURVEY (CHMS) FROM 2009-2019 Jacob Romano 1 Jessica Burnside 1 Giada Sebastiani 2 Keyur Patel 3 Alnoor Ramji 4 Mark Swain 5 Sahar Saeed 1 , 1 Queen's University, 2 McGill University Health Centre, 3 University of Toronto, 4 University of British Columbia, 5 University of Calgary Background: Prevalence estimates are crucial for understanding and enhancing the preparedness to manage, treat, and prevent the burden of MASLD
doi: 10.1093/ejendo/lvac015 14 HansenLSSparre-UlrichAHChristensenMKnopFKHartmannBHolstJJet al
You should also inform them if you're considering any herbal products marketed for 'metabolism boosting' or 'appetite control' since these directly compete with tirzepatide's mechanism and could reduce your results
While vigorous exercise immediately after eating may worsen discomfort, regular moderate-intensity activityat least 150 minutes weekly per the U.S
Dont get caught up in the marketing hype for unproven alternatives
Each one has its pros and cons, which is why it is important to speak to a health care provider